Corebridge Supplements Proxy After Merger Lawsuits, Vote Set for July 30
CRBG sits 42% above its 52-week low of $22.19.
Summary
Corebridge disclosed three stockholder lawsuits challenging its merger proxy and added supplemental disclosures to address the allegations, just nine days before the shareholder vote.
Key Events · Legal and Risk Events · CRBG
-
Three Merger Lawsuits Filed
Stockholders Johnson, Clark, and Lacoff filed complaints on July 8-10, 2026 alleging the definitive proxy statement omitted material information in violation of state laws, seeking injunctions against the vote or merger consummation.
-
Supplemental Disclosures Added
Corebridge voluntarily supplemented the proxy with new details including a planned Blackstone stockholders agreement, clarifications that executive compensation was not discussed during merger negotiations, and specific financial advisor inputs such as discount rates, terminal multiples, and share counts.
-
Vote Still Set for July 30
The special stockholder meeting to approve the Equitable merger remains scheduled for July 30, 2026; the board continues to unanimously recommend voting FOR all proposals.
-
Litigation Risk to Merger Timeline
While Corebridge believes the lawsuits are without merit, additional similar complaints or amended filings could emerge, potentially complicating or delaying the merger closing.
Analysis · CRBG · Finance
Three stockholder lawsuits filed in early July allege the proxy statement for the Equitable merger omitted material information. While Corebridge denies the claims, it is voluntarily adding supplemental disclosures to moot the litigation and avoid delays. The new details include a planned Blackstone stockholders agreement, clarifications on governance discussions, and specific inputs used by financial advisors — information that could influence how shareholders vote on July 30.
At the time of this filing, CRBG was trading at $31.54 on NYSE in the Finance sector, with a market capitalization of approximately $14.1B. The 52-week trading range was $22.19 to $36.57. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.